革命性的抗病毒疗法:在体中,用于新兴和被忽视的RNA病毒的方法
Kirti Sharma1, Manjinder Singh2, Sumesh C Sharma1
1Chitkara University Institute of Engineering and Technology, Chitkara University, Rajpura, Punjab, India.
Current pharmaceutical design
|September 3, 2024
概括
新兴的RNA病毒如SARS-CoV,埃博拉病毒和寨卡病毒构成全球威胁. 计算机辅助药物设计 (CADD) 通过虚拟评估合成化合物,加速治疗发现,为治疗方法的快速发展提供了机会.
科学领域:
- 病毒学 病毒学
- 计算化学计算化学
- 药物发现 药物发现 药物发现
背景情况:
- 新兴的RNA病毒 (SARS-CoV,埃博拉病毒,寨卡病毒,尼帕病毒,奇孔古尼亚病毒) 给全球健康带来了重大挑战.
- 尽管进行了大量投资,但对这些快速变异的病毒的有效治疗方法仍然有限.
- RNA病毒具有共同的基因组特征,这使得广泛的治疗开发变得困难.
研究的目的:
- 审查和总结在基治疗策略中对关键新兴RNA病毒的进展.
- 突出计算机辅助药物设计 (CADD) 在加速病毒性疾病的药物发现方面的潜力.
主要方法:
- 系统审查关于in silico药物设计的最先进研究文章.
- 对评估合成化合物对病毒标的抑制进行计算方法的分析.
- 在虚拟查中利用蛋白质晶体结构和结合亲和数据.
主要成果:
- 包括CADD在内的in silico方法提供了对潜在治疗化合物的高效评估.
- 虚拟查和计算算法可以在没有物理生物测试的情况下预测抑制活动.
- 蛋白质结构数据和结合亲和信息对于成功的in silico药物设计至关重要.
结论:
- 计算机辅助药物设计 (CADD) 是开发针对新兴和被忽视的RNA病毒的新疗法的一个关键战略.
- In silico方法为传统药物开发管道提供了更快,更具成本效益的替代方案.
- 在CADD的持续进步对于未来的流行病准备和应对至关重要.
相关概念视频
Experimental RNAi
6.1K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.1K
siRNA - Small Interfering RNAs
16.7K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.7K
RNA Interference
26.0K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
26.0K
Leaky Scanning
5.1K
During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA. Marilyn Kozak discovered that the sequence RCCAUGG (where R...
5.1K
Viral Mutations
32.2K
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
32.2K
Retrovirus Life Cycles
45.8K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
45.8K


